As shown in Figure S4J-K, pretreatment of tumor cells using either anti-ILT4 or anti-PD-L1 promoted the proliferation of T cells co-cultured with these tumor cells, and combined antibodies yielded most significant improvement in T cell proliferation. The gene discussed is LILRB2; the disease is neoplasm.